Nectar Lifesciences Limited (NSE:NECLIFE)
India flag India · Delayed Price · Currency is INR
11.49
+0.20 (1.77%)
Mar 10, 2026, 10:38 AM IST

Nectar Lifesciences Company Description

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally.

The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine.

It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins.

In addition, the company offers menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Nectar Lifesciences Limited
Nectar Lifesciences logo
Country India
Founded 1995
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,786
CEO Amit Chadah

Contact Details

Address:
Plot No. 110
Chandigarh, 160002
India
Phone 91 17 2504 7915
Website neclife.com

Stock Details

Ticker Symbol NECLIFE
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE023H01027
SIC Code 2833

Key Executives

Name Position
Sanjiv Goyal Chairman and MD
Sushil Kapoor Chief Financial Officer, Wholetime Director of Finance and Additional Director
Sanjaymohan Singh Rawat Company Secretary and Compliance Officer